Is CDTX or RYLD a better dividend investment in 2026?

CDTX currently yields 0.90% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between CDTX and RYLD?

CDTX has a forward dividend yield of 0.90% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 11.49 percentage points.

Home › Compare › CDTX vs RYLD

CDTX vs RYLD: Dividend Comparison 2026

CDTX yields 0.90% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $24.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CDTX

● Live price

0.90%

Share price

$221.38

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.0K

Annual income

$95.80

Full CDTX calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — CDTX vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CDTX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CDTX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CDTX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDTX

Annual income on $10K today (after 15% tax)

$76.79/yr

After 10yr DRIP, annual income (after tax)

$81.43/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, RYLD beats the other by $2,199.10/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDTX + RYLD for your $10,000?

CDTX: 50%RYLD: 50%

100% RYLD50/50100% CDTX

Portfolio after 10yr

$33.1K

Annual income

$1,389.39/yr

Blended yield

4.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CDTX right now

CDTX

Analyst Ratings

Strong

Buy

Hold

Consensus: Buy

Price Target

$181.50

-18.0% upside vs current

Range: $150.00 — $221.50

Altman Z

32.6

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDTX buys

RYLD buys

No recent congressional trades found for CDTX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCDTXRYLD

Forward yield	0.90%	12.39% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$21.0K	$45.3K ✓
Annual income after 10y	$95.80	$2,682.98 ✓
Total dividends collected	$933.00 ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CDTX vs RYLD ($10,000, DRIP)

Year	CDTX Portfolio	CDTX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$10,790	$90.34	$11,939	$1,239.34	$1.1K → RYLD
2	$11,637	$91.11	$14,158	$1,382.89	$2.5K → RYLD
3	$12,543	$91.82	$16,682	$1,532.59	$4.1K → RYLD
4	$13,514	$92.50	$19,537	$1,687.64	$6.0K → RYLD
5	$14,553	$93.14	$22,752	$1,847.20	$8.2K → RYLD
6	$15,665	$93.74	$26,355	$2,010.43	$10.7K → RYLD
7	$16,856	$94.30	$30,376	$2,176.45	$13.5K → RYLD
8	$18,131	$94.83	$34,847	$2,344.43	$16.7K → RYLD
9	$19,495	$95.33	$39,800	$2,513.54	$20.3K → RYLD
10	$20,956	$95.80	$45,269	$2,682.98	$24.3K → RYLD

CDTX vs RYLD: Complete Analysis 2026

CDTX — Stock

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Full CDTX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this CDTX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDTX vs SCHD CDTX vs JEPI CDTX vs O CDTX vs KO CDTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.